Mereo Biopharma Group is a biotechnology company focused on the development and commercialization of innovative therapeutics for patients with rare diseases and oncology

The company aims to address significant unmet medical needs by advancing a portfolio of product candidates that target specific conditions with potential for significant clinical impact. Mereo leverages both in-house research and strategic partnerships to bring new treatment options to market, enhancing the quality of life for impacted patients through novel therapeutic approaches. Their commitment encompasses all stages of drug development, from preclinical research through clinical trials and beyond.